However, in KRAS-mutated pancreatic cancer, Li et al. described that TAP1 overexpression increased resistance to MEK inhibitors by facilitating drug transport out of cells and promoting cancer stemness48. Here, TAP1 is linked to familial pancreatic carcinoma.